Abbott Products GmbH
Records under this name other than the patents Abbott Products GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,273,348 | Lipase Variants for Pharmaceutical Use now held by Novozymes A/S In force · High confidence | In force | High confidence | |
| US 11,266,607 | Process for the Manufacture and Use of Pancreatin Micropellet Cores now held by AbbVie Pharmaceuticals GmbH In force · High confidence | In force | High confidence | |
| US 9,080,193 | Preparation of (3aS,7aR)-HEXAHYDROISOBENZOFURAN-1(3H)-ONE by Catalyzed Biological Resolution of Dimethyl CYCLOHEXANE-1,2-Dicarboxylate now held by AbbVie Inc. In force · High confidence | In force | High confidence | |
| US 9,453,007 | Hepatitis C Inhibitors and Uses Thereof now held by AbbVie Inc. In force · High confidence | In force | High confidence | |
| US 9,567,355 | Hepatitis C Inhibitors and Uses Thereof now held by AbbVie Inc. In force · High confidence | In force | High confidence | |
| US 9,173,887 | Hepatitis C Inhibitors and Uses Thereof now held by AbbVie Inc. In force · High confidence | In force | High confidence | |
| US 10,704,037 | Processes for the Manufacture and Use of Pancreatin Term ended Term ended Jul 27, 2026 · High confidence | Term ended | Term ended Jul 27, 2026 | High confidence |
| US 8,802,087 | Pharmaceutical Compositions of Lipase-Containing Products, in Particular of Pancreatin Term ended Term ended Mar 22, 2025 · High confidence | Term ended | Term ended Mar 22, 2025 | High confidence |
| US 8,058,264 | Pharmaceutical Compositions Comprising CB1 Cannabinoid Receptor Antagonists and Potassium Channel Openers for the Treatment of Obesity and Related Conditions Lapsed on the fee record Ended Nov 15, 2023 · High confidence | Lapsed on the fee record | Ended Nov 15, 2023 | High confidence |
| US 7,122,357 | Method for the Treatment of Diabetes Term ended Term ended Jul 11, 2021 · High confidence | Term ended | Term ended Jul 11, 2021 | High confidence |